Market Place
Sourcing Support
Luxembourg Law Mandates Issuer Transparency Under Article 13
03 Jul 2025 //
GLOBENEWSWIRE
Alvotech and Advanz Pharma Partner for Biosimilar to Cimzia®
01 Jul 2025 //
GLOBENEWSWIRE
Granting of Stock Options and Vesting of Restricted Share Units
01 Jul 2025 //
GLOBENEWSWIRE
Alvotech Lenders Cut Interest on Loan Facility
26 Jun 2025 //
GLOBENEWSWIRE
Main Results of 2025 Annual and Extraordinary General Meeting
25 Jun 2025 //
GLOBENEWSWIRE
Positive Results from Efficacy Study for Biosimilar to Xolair®
25 Jun 2025 //
GLOBENEWSWIRE
EMA Recommends Approval of Alvotech’s Eylea Biosimilar
23 Jun 2025 //
GLOBENEWSWIRE
Alvotech Completes Private Placement with SDRs and Shares
11 Jun 2025 //
GLOBENEWSWIRE
Alvotech`s Private Placement Completed with SDRs and Shares
11 Jun 2025 //
GLOBENEWSWIRE
Alvotech at Goldman Sachs Global Healthcare Conference Miami
06 Jun 2025 //
GLOBENEWSWIRE
Alvotech presents at Goldman Sachs Global Healthcare Conference
06 Jun 2025 //
GLOBENEWSWIRE
Alvotech & Dr. Reddy’s Collab to co-develop Keytruda
05 Jun 2025 //
PRESS RELEASE
Alvotech Plans Private Placement of 7.5 M SDRs and Shares
04 Jun 2025 //
GLOBENEWSWIRE
Alvotech completes private placement, raises SEK 750 million
04 Jun 2025 //
GLOBENEWSWIRE
Alvotech Acquires Xbrane R&D Organization Cimzia Biosimilar
04 Jun 2025 //
GLOBENEWSWIRE
Alvotech Presents at Jefferies Global Healthcare Conference 2025
02 Jun 2025 //
GLOBENEWSWIRE
Alvotech, Advanz Pharma Extend Partnership for 3 More Biosimilars
28 May 2025 //
GLOBENEWSWIRE
Alvotech Annual General Meeting to be held June 25, 2025
26 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
23 May 2025 //
GLOBENEWSWIRE
Alvotech`s Shares Trade on Nasdaq Stockholm Today
19 May 2025 //
GLOBENEWSWIRE
Alvotech Appoints DNB Carnegie for Nasdaq Stockholm Liquidity
19 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
16 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
13 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
09 May 2025 //
GLOBENEWSWIRE
Alvotech Meets Investors at BofA Securities Healthcare Conference
09 May 2025 //
GLOBENEWSWIRE
Alvotech Publishes Prospectus for Nasdaq Stockholm listing
08 May 2025 //
GLOBENEWSWIRE
US Tariffs on Pharmaceuticals to Have Minimal Impact on Alvotech
07 May 2025 //
GLOBENEWSWIRE
Alvotech Reports Q1 2025 Results and Business Update
07 May 2025 //
GLOBENEWSWIRE
Teva & Alvotech Announce FDA Approval for Selarsdi with Stelara
06 May 2025 //
GLOBENEWSWIRE
Alvotech to Webcast Q1 2025 Financial Results on May 8, 2025
02 May 2025 //
GLOBENEWSWIRE
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
27 Mar 2025 //
GLOBENEWSWIRE
Alvotech Reports Record 2024 Results and Business Update
26 Mar 2025 //
GLOBENEWSWIRE
Alvotech Acquires Xbrane’s R&D in Sweden, Strengthens Biosimilars
20 Mar 2025 //
GLOBENEWSWIRE
Alvotech & Dr. Reddy’s Announce FDA acceptance of BLA for AVT03
19 Mar 2025 //
PRESS RELEASE
Alvotech, Dr. Reddy’s FDA Review For Prolia, Xgeva Biosim
18 Mar 2025 //
BUSINESSWIRE
Alvotech Meets Investors at Barclays Global Healthcare Conference
07 Mar 2025 //
GLOBENEWSWIRE
Alvotech to Report 2024 Financial Results on March 26, 2025
24 Feb 2025 //
GLOBENEWSWIRE
Alvotech, Teva’s BLA For AVT06 Biosimilar To Eylea Accepted By FDA
18 Feb 2025 //
GLOBENEWSWIRE
Alvotech`s Biologic Simlandi Receives Suppl Approval in US
14 Feb 2025 //
FDA
Alvotech, Teva BLA Filing Accepted For AVT05 Biosimilar To Simponi
27 Jan 2025 //
GLOBENEWSWIRE
Alvotech Added to Nasdaq Biotech Index, Effective Dec 23, 2024
23 Dec 2024 //
GLOBENEWSWIRE
Alvotech Reports 2024 Results for First Nine Months Again
13 Nov 2024 //
GLOBENEWSWIRE
Alvotech Reports 2024 Results for First Nine Months
13 Nov 2024 //
GLOBENEWSWIRE
Alvotech to Attend Citi & Evercore Conferences in Dec 2024
07 Nov 2024 //
GLOBENEWSWIRE
EMA Accepts Marketing Application for AVT05 Biosimilar to Simponi®
04 Nov 2024 //
GLOBENEWSWIRE
Alvotech to Report 2024 Results on Nov 13, Call on Nov 14
30 Oct 2024 //
GLOBENEWSWIRE
Alvotech to Present at Jefferies 2024 London Healthcare Conference
25 Oct 2024 //
GLOBENEWSWIRE
Alvotech And Teva Announce FDA Approval Of SELARSDI™ Presentation
22 Oct 2024 //
GLOBENEWSWIRE
Alvotech`s Biologic Selarsi (Ustekinumab) Receives Approval in US
18 Oct 2024 //
FDA
EMA Accepts AVT03 Marketing Application For Prolia Biosimilar
10 Oct 2024 //
GLOBENEWSWIRE
Alvotech Initiates AVT16 Confirmatory Patient Study
25 Sep 2024 //
GLOBENEWSWIRE
Alvotech To Participate In Morgan Stanley Global Healthcare Conference
26 Aug 2024 //
GLOBENEWSWIRE
Alvotech`s Biologic Simlandi (Adalimumab) Receives Suppl Approvals in US
26 Aug 2024 //
FDA
EMA Accepts Marketing Application For AVT06, Biosimilar To Eylea (Aflibercept)
15 Aug 2024 //
GLOBENEWSWIRE
Alvotech Reports Record Revenues And Adjusted EBITDA For Q2 And H1 2024
15 Aug 2024 //
GLOBENEWSWIRE
Alvotech To Report H1 2024 Results On August 15
01 Aug 2024 //
GLOBENEWSWIRE
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In Europe
23 Jul 2024 //
PHARMABIZ
STADA And Alvotech Launch Uzpruvo, First Ustekinumab Biosimilar In EU
22 Jul 2024 //
GLOBENEWSWIRE
Alvotech Announces Closing of Private Debt Financing
11 Jul 2024 //
GLOBENEWSWIRE
Alvotech Reports Positive Results For AVT03, Biosimilar To Prolia And Xgeva
02 Jul 2024 //
GLOBENEWSWIRE
